KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer.

Marta De DonatoGabriele BabiniSimona MozzettiMarianna ButtarelliAlessandra CiucciGloria ArduiniMaria Cristina De RosaGiovanni ScambiaDaniela Gallo

Published in: Journal of experimental & clinical cancer research : CR (2020)

Results from the present study provide the first evidence for an oncogenic role of KLF7 in HGSOC, suggesting it as a promising prognostic marker and therapeutic target.

Keyphrases

high grade
low grade
transcription factor